Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Steele

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Clinical Immunology (Orlando, Fla.)|July 18, 2024
Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency DisordersRohan Ameratunga, Hilary Longhurst, Euphemia Leung, et al.
Clinical Reviews in Allergy & Immunology|December 1, 2025
Common Variable Immunodeficiency Disorders: A perspective from New ZealandRohan Ameratunga, Hilary J Longhurst, Klaus Lehnert, et al.
Frontiers in Immunology|December 15, 2016
Hereditary Angioedema as a Metabolic Liver Disorder: Novel Therapeutic Options and Prospects for CureRohan Ameratunga, Adam Bartlett, John McCall, et al.
The New Zealand Medical Journal|May 9, 2006
Anaphylaxis management: the essential role of adrenaline (epinephrine) auto-injectors. Should PHARMAC fund them in New Zealand?Penny Fitzharris, Marianne Empson, Rohan Ameratunga, et al.
Frontiers in Immunology|August 9, 2021
Are All Primary Immunodeficiency Disorders Inborn Errors of Immunity?Rohan Ameratunga, Hilary Longhurst, Klaus Lehnert, et al.
Journal of Clinical Pathology|October 10, 2022
Critical role of diagnostic SARS-CoV-2 T cell assays for immunodeficient patientsRohan Ameratunga, See-Tarn Woon, Richard Steele, et al.
Expert Review of Clinical Immunology|May 5, 2022
Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2Rohan Ameratunga, See-Tarn Woon, Richard Steele, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 25, 2022
SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?Rohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
Scandinavian Journal of Immunology|November 21, 2025
Common Variable Immune Deficiency Disorders (CVID) in the Indigenous Māori of Aotearoa (New Zealand) Are Associated With a High Prevalence of Bronchiectasis and Complete IgA DeficiencyRohan Ameratunga, Catherine A Byrnes, Anthony Jordan, et al.
Expert Review of Clinical Immunology|February 21, 2022
The (apparent) antibody paradox in COVID-19Rohan Ameratunga, See-Tarn Woon, Edward Lea, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Clinical Immunology (Orlando, Fla.)|July 18, 2024
Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency DisordersRohan Ameratunga, Hilary Longhurst, Euphemia Leung, et al.
Clinical Reviews in Allergy & Immunology|December 1, 2025
Common Variable Immunodeficiency Disorders: A perspective from New ZealandRohan Ameratunga, Hilary J Longhurst, Klaus Lehnert, et al.
Frontiers in Immunology|December 15, 2016
Hereditary Angioedema as a Metabolic Liver Disorder: Novel Therapeutic Options and Prospects for CureRohan Ameratunga, Adam Bartlett, John McCall, et al.
The New Zealand Medical Journal|May 9, 2006
Anaphylaxis management: the essential role of adrenaline (epinephrine) auto-injectors. Should PHARMAC fund them in New Zealand?Penny Fitzharris, Marianne Empson, Rohan Ameratunga, et al.
Frontiers in Immunology|August 9, 2021
Are All Primary Immunodeficiency Disorders Inborn Errors of Immunity?Rohan Ameratunga, Hilary Longhurst, Klaus Lehnert, et al.
Journal of Clinical Pathology|October 10, 2022
Critical role of diagnostic SARS-CoV-2 T cell assays for immunodeficient patientsRohan Ameratunga, See-Tarn Woon, Richard Steele, et al.
Expert Review of Clinical Immunology|May 5, 2022
Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2Rohan Ameratunga, See-Tarn Woon, Richard Steele, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 25, 2022
SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?Rohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
Scandinavian Journal of Immunology|November 21, 2025
Common Variable Immune Deficiency Disorders (CVID) in the Indigenous Māori of Aotearoa (New Zealand) Are Associated With a High Prevalence of Bronchiectasis and Complete IgA DeficiencyRohan Ameratunga, Catherine A Byrnes, Anthony Jordan, et al.
Expert Review of Clinical Immunology|February 21, 2022
The (apparent) antibody paradox in COVID-19Rohan Ameratunga, See-Tarn Woon, Edward Lea, et al.
Pageof 6